Discreet, evidence-based care for North Carolina women — HSDD, perimenopause, menopausal hormone therapy, low-dose testosterone for women, and vaginal estrogen — delivered by clinicians licensed in North Carolina.
Our providers are licensed by the North Carolina Medical Board to deliver comprehensive telehealth services statewide.
Hypoactive sexual desire disorder affects about 1 in 10 adult women. Treatable with FDA-approved Addyi or Vyleesi, low-dose testosterone, and addressing modifiable contributors like SSRIs and contraceptive choice.
Modern menopausal hormone therapy — typically transdermal estradiol with cyclic or continuous progesterone — for hot flashes, sleep disruption, libido changes, and mood symptoms.
Local vaginal estrogen, DHEA inserts (prasterone), and ospemifene for genitourinary symptoms with very low systemic absorption.
Off-label and supported by international guidelines for postmenopausal HSDD. Carefully titrated based on baseline labs, with quarterly monitoring.
North Carolina has updated telehealth regulations to support virtual care delivery while maintaining patient safety standards.
North Carolina pharmacies in Charlotte, Raleigh, the Triad, and throughout mountain and coastal communities ensure prescription access.
Visits, intake forms, and lab results are protected health information. Medication ships in plain, unmarked packaging anywhere in North Carolina. If you choose cash-pay, no insurance EOB is sent to your household.